Chester County cell therapy developer Fibrocell Science Inc. of Exton expects to file its first quarter financial report this week after a five-day delay to fix accounting issues affecting quarterly reports as far back as the third quarter of 2011.
Fibrocell advised the Securities and Exchange Commission about needing “additional time necessary to address a non-cash, non-operating issue related to its historical accounting treatment of warrants” discovered through an internal audit ordered by management, according to a report in the Philadelphia Business Journal.
Along with the late filing of its first quarter report, the company announced it will restate its financial documents for the previous periods as well.
Read the entire Philadelphia Business Journal article here.
